DHHB in cosmetics: UVA filter, DnHexP impurity and regulations
DHHB is an organic filter used to provide UVA protection in sunscreens. This article summarizes published data on its photostability, skin penetration and the EU safety assessment, as well as the 2024–2026 developments around DnHexP, a phthalate impurity that may be present in the raw material.
DHHB (INCI name: Diethylamino Hydroxybenzoyl Hexyl Benzoate) is an oil-soluble organic UV filter that absorbs mainly in the UVA range. In ASEAN, DHHB is permitted in cosmetics at a maximum concentration of 10% (Annex VII, Ref 28). In 2008, the EU scientific committee (SCCP) concluded that the use of DHHB at up to 10% in cosmetics, including sunscreen products, does not pose a risk to consumers (SCCP/1166/08).
Since 2024, DHHB has drawn attention because of an impurity that can form during manufacturing: di-n-hexyl phthalate (DnHexP), a phthalate banned as a cosmetic ingredient. In 2026, the EU set a limit of 10 ppm for DnHexP in DHHB. This article summarizes the published data and the points brand owners need to control.
1. What is DHHB?
According to PubChem, DHHB has the chemical name hexyl 2-[4-(diethylamino)-2-hydroxybenzoyl]benzoate, the formula C24H31NO4, a molecular weight of 397.5 g/mol and CAS number 302776-68-7. The SCCP assessment dossier (2008) describes the raw material as a fine, off-white powder with a minimum purity of 98% and a melting point of 54 °C. DHHB is practically insoluble in water (below 0.01 mg/L at 20 °C) and has a log Pow of 6.2, meaning it is highly lipophilic; in formulas, DHHB is dissolved in the oil phase.
2. Mechanism: a UVA-absorbing filter
DHHB absorbs UV energy within the product film on the skin. Measured in methanol, the absorption spectrum of DHHB has its main maximum at 356 nm, with two other maxima at 266 nm and 210 nm (SCCP/1166/08). The SCCP classifies DHHB as an oil-soluble UVA filter. Background on UVA and UVB is covered in the article light and the skin (in Vietnamese).
The SPF and UVA protection level stated on the label result from the whole combination of filters and the cream base, and must be measured on the finished product (see SPF: what it means and how it is tested (in Vietnamese)).
3. Photostability and combination with avobenzone
| Question | Data (according to the sources reviewed) | Source |
|---|---|---|
| Is DHHB stable under UV light? | In the sunscreen formulas tested, DHHB was assessed as photostable (measured by HPLC and spectrophotometry after irradiation) | Kawakami et al., 2017 (in vitro) |
| Does DHHB make avobenzone (in Vietnamese) more stable? | No. DHHB does not increase the photostability of avobenzone; the two substances interact through a static quenching mechanism | Kawakami et al., 2017 (in vitro) |
| Stability of the raw material | Stable for 3 months at 25 °C, 60% humidity and at 40 °C, 75% humidity | SCCP/1166/08 |
This is a laboratory study; the abstract does not state the formula composition or the concentration of each filter. Practical point: do not regard DHHB as an “avobenzone stabilizer.” Formulas containing avobenzone need a filter that already has avobenzone stabilization data, for example bemotrizinol (BEMT) (in Vietnamese), and photostability testing on the finished product.
4. Does DHHB penetrate the skin and enter the bloodstream?
Pig skin (in vitro): an oil-in-water emulsion containing 10% DHHB, applied at 2 mg/cm² for 24 hours: no DHHB was found passing through the skin into the receptor fluid; 0.77% of the applied dose was in the upper layers of the stratum corneum (separated by tape stripping); the amount in the deeper skin layers, which the SCCP took as the dermal absorption, was 0.10 ± 0.12 µg/cm² (0.04 ± 0.05% of the applied dose; highest value 0.15%). The SCCP used the 0.15% figure to calculate the margin of safety (SCCP/1166/08).
In humans: after a single oral dose and a single dermal dose, Stoeckelhuber and colleagues (2020) identified three main metabolites in urine, accounting for 52% of the oral dose (the abstract does not state how many people received the doses). In 58 people not knowingly using DHHB, all three metabolites were quantifiable in 26% of urine samples; DHHB intake was estimated at about 8.1–9.3 µg/day. Most of the authors are affiliated with a private analytical laboratory; one author works for a company that manufactures DHHB.
Archived samples in Germany: in 250 24-hour urine samples (2000–2021), two DHHB-specific metabolites were found in 18% and 13% of samples, first in 2012; the median estimated intake was 37 ng/kg body weight/day. The samples were collected in winter, so they mainly reflect sources other than sunscreen (Scherer et al., 2025; authors from a private laboratory, a research institute and the German Federal Environment Agency).
5. The DnHexP impurity: developments in 2024–2026
| Date | Details | Source |
|---|---|---|
| March 21, 2024 | The German Federal Institute for Risk Assessment (BfR) assessed the detection of MnHexP (a metabolite of DnHexP and some other phthalates) in urine from children and adults. The BfR proposed a provisional tolerable daily intake (TDI) of 63 µg/kg body weight/day for DnHexP; exposure derived from urine reached at most 4.3% of the TDI. Assuming a sunscreen containing 10% of a UV filter contaminated with 0.3% DnHexP, adverse health effects are very unlikely. The source of MnHexP has not been conclusively identified. | BfR, Opinion 017/2024 |
| February 2025 (preliminary), June 26, 2025 (final version) | Testing in Germany of 57 sunscreens (2020–2023): 21 of the 40 products containing DHHB contained DnHexP (up to 44 mg/kg); in the 17 products without DHHB, none was detected. The EU scientific committee (SCCS) calculated a maximum safe level of 0.026% (260 ppm) DnHexP in DHHB, where DHHB is used at up to 10% and the impurity is unavoidable; because manufacturing processes achieving 1 ppm already exist, the SCCS considered that 1 ppm should be the target. | SCCS/1678/25 |
| March 2025 | Re-analysis of an oral DHHB dosing experiment: excretion of DnHexP metabolites increased with the dose, due to the impurity. The authors suggest that this impurity may contribute to DnHexP exposure in people using sunscreen products containing contaminated DHHB. | Scherer et al., 2025 |
| April 27, 2026 (published in the Official Journal on April 28, 2026) | The EU amended entry 28 of Annex VI to Regulation (EC) No 1223/2009: DHHB at a maximum of 10%; DnHexP, as an unavoidable trace impurity, must not exceed 10 ppm. Products that do not meet these conditions must not be placed on the EU market from January 1, 2027, and must not be made available on the EU market from July 1, 2028. The EU chose 10 ppm rather than 1 ppm because of costs, particularly for small and medium-sized enterprises. | Regulation (EU) 2026/909 |
According to the SCCS, DnHexP is classified as toxic for reproduction, Category 1B (CLP); the main concern is its effect on testosterone production in the fetal testis, based on research in pregnant rats. This concern relates to the impurity: the SCCS notes that there is no new information on DHHB itself since the 2008 assessment.
In ASEAN, Annex II (version 2026-1) prohibits “Dihexyl phthalate” (CAS 84-75-3, Ref 1559) and “1,2-Benzenedicarboxylic acid, dihexyl ester, branched and linear” (CAS 68515-50-4, Ref 1583). Ref 28 of Annex VII version 2025-2 lists only the 10% maximum and does not yet include a DnHexP condition like the EU's.
6. Safety: irritation, allergy and groups needing caution
- SCCP assessment (2008): low acute oral toxicity; no skin irritation in guinea pigs with application for up to 14 days; transient eye irritation in rabbits; not mutagenic in in vitro tests, including under irradiation; no phototoxicity or photosensitization. The skin sensitization test in guinea pigs could not be evaluated. Assuming daily use of 36 g of cosmetics all containing 10% DHHB, the margin of safety is 2,222. Spray formats: the SCCP considered only the dermal route and did not assess the inhalation route.
- Contact allergy: Searching PubMed, we found just one case report of clinically relevant sensitization to DHHB and fragrances (Gatica-Ortega et al., 2022; a short article with no abstract on PubMed) — not enough to estimate frequency.
- Pregnant or breastfeeding women, young children: there are not enough data specific to DHHB; it is advisable to consult a doctor. The SCCS safe impurity level was calculated for children, the group considered most sensitive.
7. Concentrations and regulations
| Market | Maximum concentration | Main conditions |
|---|---|---|
| ASEAN (Annex VII, version 2025-2, Ref 28) | 10% | No specific limit or warning; primary sunscreen products must carry the general warning “Do not stay too long in the sun, even while using a sunscreen product” |
| EU (Annex VI, entry 28, as amended by Regulation (EU) 2026/909) | 10% | DnHexP in DHHB must not exceed 10 ppm; applies in two stages, January 1, 2027 and July 1, 2028 |
We have not yet found a verified published source on typical use levels; the level in each formula is set by measuring SPF and UVA on the finished product.
8. Perspective for brand owners (B2B)
- Sourcing the raw material: request DnHexP results for each batch (method, detection limit). Products exported to the EU must meet a maximum of 10 ppm; the SCCS recommends a target of 1 ppm.
- Dissolution: in factory practice, DHHB is fully dissolved in the hot oil phase before emulsification; check that it does not recrystallize during stability studies.
- Proportionate claims: avoid “does not penetrate the skin,” “safe for everyone,” “coral-friendly.” Only mention DnHexP information when you have test results for the raw material batch or the finished product.
Butter-C uses DHHB in contract manufacturing of sunscreens, combining it with other filters within the limits of ASEAN Annex VII, requiring impurity documentation from suppliers, and verifying SPF and UVA on the finished product at an independent testing laboratory.
Frequently asked questions
Do sunscreens with DHHB contain phthalates?
DHHB is not a phthalate, but it may contain the DnHexP impurity depending on the manufacturing process. In the German survey, DnHexP was not detected in 19 of the 40 sunscreens containing DHHB (SCCS/1678/25). The EU limits this impurity to 10 ppm in DHHB.
Should I stop using sunscreens containing DHHB?
According to the BfR (2024), even assuming a filter contaminated with 0.3% DnHexP, adverse health effects are very unlikely; the levels measured in sunscreens at that time were much lower than this assumed level.
Does DHHB get into the bloodstream?
On pig skin, DHHB did not pass through the skin into the receptor fluid; the portion the SCCP counted as dermal absorption was at most 0.15% of the applied dose. In humans, DHHB metabolites are found in urine, with low estimated exposure (Stoeckelhuber et al., 2020; Scherer et al., 2025).
Can pregnant women and children use sunscreens containing DHHB?
There are not enough data specific to DHHB in pregnant women and young children; it is advisable to consult a doctor.
References
- Scientific Committee on Consumer Products (SCCP). Opinion on diethylamino hydroxybenzoyl hexyl benzoate, COLIPA n° S83 (SCCP/1166/08, adopted 15 April 2008). https://ec.europa.eu/health/ph_risk/committees/04_sccp/docs/sccp_o_130.pdf
- Scientific Committee on Consumer Safety (SCCS). Scientific Advice on the safety of Diethylamino Hydroxybenzoyl Hexyl Benzoate – DHHB – S83 (SCCS/1678/25, final version 26 June 2025). https://health.ec.europa.eu/publications/sccs-scientific-advice-safety-diethylamino-hydroxybenzoyl-hexyl-benzoate-dhhb-s83_en
- European Commission. Commission Regulation (EU) 2026/909 of 27 April 2026 amending Regulation (EC) No 1223/2009 … and DHHB in cosmetic products. OJ L, 28.4.2026. https://publications.europa.eu/resource/celex/32026R0909
- Bundesinstitut für Risikobewertung (BfR). MnHexP in Urinproben: Bewertung des gesundheitlichen Risikos. Stellungnahme 017/2024, 21. März 2024. https://www.bfr.bund.de/cm/343/mnhexp-in-urinproben-bewertung-des-gesundheitlichen-risikos.pdf
- Kawakami CM et al. Diethylamino hydroxybenzoyl hexyl benzoate (DHHB) as additive to the UV filter avobenzone in cosmetic sunscreen formulations - Evaluation of the photochemical behavior and photostabilizing effect. Eur J Pharm Sci. 2017. PMID 28042100
- Stoeckelhuber M et al. Human metabolism and urinary excretion kinetics of the UV filter Uvinul A plus® after a single oral or dermal dosage. Int J Hyg Environ Health. 2020. PMID 32174481
- Scherer M et al. Assessing the exposure to the UV filter DHHB in urine samples from the German Environmental Specimen Bank (2000-2021): Evaluating the impact of a potential impurity of di-n-hexyl phthalate in DHHB. Int J Hyg Environ Health. 2025. PMID 40117958
- Gatica-Ortega ME et al. Relevant sensitization to diethylamino hydroxybenzoyl hexyl benzoate and fragrances in a patient with frontal fibrosing alopecia and acquired dermal macular hyperpigmentation. Contact Dermatitis. 2022. PMID 35506507
BUTTER-C